ACHV News and Press, Achieve Life Sciences Inc. From 04/26/24

2024-04-26 17:01:59 ET More on Achieve Life Sciences Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns Achieve Life Sciences stock falls 11% amid FDA update, securities sale Seeking Alpha’s Quant Rating on Achieve Life S...

SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it ...

2024-04-17 17:41:31 ET More on Achieve Life Sciences Achieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x Returns Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript Achieve Life Sciences stock falls 11% amid FDA update, s...

SEATTLE and VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced tha...

2024-04-04 06:30:32 ET Summary Achieve Life Sciences is working to commercialize the smoking cessation drug Cytisinicline, which has shown promising results in clinical trials. The drug has a superior safety profile compared to existing treatment options and has the potential to a...

2024-03-28 21:03:08 ET Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Conference Call March 28, 2024 4:30 PM ET Company Participants Nicole Jones – Investor Relations John Bencich – Chief Executive Officer Cindy Jacobs – President and Ch...

2024-03-28 16:04:11 ET More on Achieve Life Sciences Achieve Life Sciences stock falls 11% amid FDA update, securities sale Seeking Alpha’s Quant Rating on Achieve Life Sciences Historical earnings data for Achieve Life Sciences Financial information f...

SEATTLE and VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fou...

Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...

2024-03-27 17:35:53 ET More on Achieve Life Sciences Achieve Life Sciences stock falls 11% amid FDA update, securities sale Seeking Alpha’s Quant Rating on Achieve Life Sciences Historical earnings data for Achieve Life Sciences Financial information f...